Login
Super Investors Invesco NASDAQ Future Gen 200 ETF

Invesco NASDAQ Future Gen 200 ETF

Invesco Exchange-traded Fund Trust Ii · net assets $22.5M · 206 holdings as of August 31, 2026. Monthly N-PORT disclosure: the full book, not just equities.

Asset mix

EC: 75.0% · STIV: 25.0%

Financial position

Total assets
$30M
Total liabilities
$7.44M
Net assets
$22.5M
Assets attributable to miscellaneous securities
$0
Assets invested in controlled foreign corporations
$0
Borrowings payable within one year
$0
Payable to controlled companies within one year
$0
Payable to other affiliates within one year
$0
Other liabilities payable within one year
$0
Borrowings payable after one year
$0
Payable to controlled companies after one year
$0
Payable to other affiliates after one year
$0
Other liabilities payable after one year
$0
Payables for delayed-delivery investments
$0
Payables for standby commitments
$0
Liquidation preference of outstanding preferred stock
$0
Cash not reported in Parts C or D
$0

Monthly flows and gains

Month 1 Month 2 Month 3
Sales $8.32M $1.32M $0
Reinvestment $0 $0 $0
Redemptions $6.36M $0 $0
Net realized gain (non-derivative) $2.32M -$141 -$3.24K
Net unrealized appreciation (non-derivative) -$1.84M -$1.43M $1.26M

The three months of the reporting period, as filed; month 3 ends August 31, 2026.

Filing details

Registrant
Invesco Exchange-traded Fund Trust Ii
Registrant CIK
1378872
Registrant LEI
O540V2L4S174Y60FMD36
Series
Invesco NASDAQ Future Gen 200 ETF
Series ID
S000077288
Series LEI
549300GPI35ZCTF27915
SEC file number
811-21977
Address
3500 Lacey Road, Suite 700, Downers Grove, US-IL, 60515, US
Phone
800-983-0903
Form
NPORT-P
Filed
October 30, 2026
Report period ends
August 31, 2026
Report month ends
August 31, 2026
Accession number
000137887226001862
Holding Value % of net assets
Invesco Private Prime Fund STIV $5.37M 23.85%
Invesco Private Government Fund STIV $2.07M 9.19%
Cybin Inc. EC $289K 1.28%
Quantum Corp. EC $280K 1.24%
Xencor, Inc. EC $256K 1.14%
10x Genomics, Inc. EC $246K 1.09%
Agenus Inc. EC $243K 1.08%
Iovance Biotherapeutics, Inc. EC $223K 0.99%
Neuronetics, Inc. EC $206K 0.91%
Newell Brands Inc. EC $205K 0.91%
Varex Imaging Corp. EC $202K 0.90%
Atricure, Inc. EC $195K 0.87%
Omeros Corp. EC $190K 0.84%
Rapid7, Inc. EC $179K 0.80%
Precigen, Inc. EC $178K 0.79%
Rigel Pharmaceuticals, Inc. EC $169K 0.75%
Exagen Inc. EC $165K 0.73%
Personalis, Inc. EC $164K 0.73%
Trisalus Life Sciences, Inc. EC $162K 0.72%
Merit Medical Systems, Inc. EC $161K 0.71%
Anika Therapeutics, Inc. EC $160K 0.71%
Azenta, Inc. EC $159K 0.71%
Progress Software Corp. EC $157K 0.70%
Angiodynamics, Inc. EC $157K 0.70%
Millerknoll, Inc. EC $156K 0.69%
Senseonics Holdings, Inc. EC $152K 0.67%
Orthopediatrics Corp. EC $152K 0.67%
Si-bone, Inc. EC $151K 0.67%
Q32 Bio Inc. EC $150K 0.67%
Aclaris Therapeutics, Inc. EC $149K 0.66%
Interdigital, Inc. EC $148K 0.66%
Dropbox, Inc. EC $146K 0.65%
Tandem Diabetes Care, Inc. EC $143K 0.63%
Icu Medical, Inc. EC $143K 0.63%
Aquestive Therapeutics, Inc. EC $142K 0.63%
Autolus Therapeutics PLC EC $140K 0.62%
Mimedx Group, Inc. EC $138K 0.61%
Cartesian Therapeutics, Inc. EC $137K 0.61%
Ligand Pharmaceuticals Inc. EC $137K 0.61%
Alphatec Holdings, Inc. EC $135K 0.60%
Arqit Quantum Inc. EC $134K 0.60%
Lyft, Inc. EC $134K 0.59%
Clearpoint Neuro, Inc. EC $133K 0.59%
Geron Corp. EC $133K 0.59%
Ironwood Pharmaceuticals, Inc. EC $133K 0.59%
Skyx Platforms Corp. EC $132K 0.59%
Sarepta Therapeutics, Inc. EC $131K 0.58%
Itron, Inc. EC $131K 0.58%
Journey Medical Corp. EC $131K 0.58%
Immersion Corp. EC $131K 0.58%
Commvault Systems, Inc. EC $129K 0.57%
Spruce Biosciences, Inc. EC $128K 0.57%
Agios Pharmaceuticals, Inc. EC $128K 0.57%
Onespan Inc. EC $128K 0.57%
Tonix Pharmaceuticals Holding Corp. EC $128K 0.57%
Gentherm Inc. EC $127K 0.56%
Fox Factory Holding Corp. EC $127K 0.56%
Innospec Inc. EC $126K 0.56%
Aviat Networks, Inc. EC $125K 0.56%
Pacira Biosciences, Inc. EC $125K 0.55%

Showing top 60 of 206 holdings.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support